Cargando…

Personalising lung cancer screening: An overview of risk‐stratification opportunities and challenges

Randomised clinical trials have shown the efficacy of computed tomography lung cancer screening, initiating discussions on whether and how to implement population‐based screening programs. Due to smoking behaviour being the primary risk‐factor for lung cancer and part of the criteria for determining...

Descripción completa

Detalles Bibliográficos
Autores principales:	ten Haaf, Kevin, van der Aalst, Carlijn M., de Koning, Harry J., Kaaks, Rudolf, Tammemägi, Martin C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	Invited Review Series on Personalized Prevention
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251929/ https://www.ncbi.nlm.nih.gov/pubmed/33783822 http://dx.doi.org/10.1002/ijc.33578

Ejemplares similares

Implementation of lung cancer screening: what are the main issues?
por: van der Aalst, Carlijn M., et al.
Publicado: (2021)

Personalized strategies in population screening for prostate cancer
por: Remmers, Sebastiaan, et al.
Publicado: (2020)

Risk‐stratified strategies in population screening for colorectal cancer
por: Lansdorp‐Vogelaar, Iris, et al.
Publicado: (2021)

Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada
por: ten Haaf, Kevin, et al.
Publicado: (2017)

All‐cause mortality versus cancer‐specific mortality as outcome in cancer screening trials: A review and modeling study
por: Heijnsdijk, Eveline A. M., et al.
Publicado: (2019)

Personalised pulmonary rehabilitation in COPD
por: Wouters, Emiel F.M., et al.
Publicado: (2018)

Contemporary issues in the implementation of lung cancer screening
por: Lam, Stephen, et al.
Publicado: (2021)

Personalised medicine for nonsmall cell lung cancer
por: Mascaux, Céline, et al.
Publicado: (2017)

Personalised medicine in asthma: time for action: Number 1 in the Series “Personalised medicine in respiratory diseases” Edited by Renaud Louis and Nicolas Roche
por: Chung, Kian Fan
Publicado: (2017)

Personalised medicine in interstitial lung diseases: Number 6 in the Series “Personalised medicine in respiratory diseases” Edited by Renaud Louis and Nicolas Roche
por: Kokosi, Maria A., et al.
Publicado: (2018)

Microbiology challenges and opportunities in the circular economy
por: O'Connor, Kevin E.
Publicado: (2021)

Challenges and opportunities in antimicrobial resistance research
por: Baker, Stephen
Publicado: (2021)

Lung cancer screening and smoking cessation efforts
por: Moldovanu, Dana, et al.
Publicado: (2021)

Genomic-informed pathogen surveillance in Africa: opportunities and challenges
por: Inzaule, Seth C, et al.
Publicado: (2021)

Genomic surveillance to combat COVID-19: challenges and opportunities
por: Robishaw, Janet D, et al.
Publicado: (2021)

The effects of different recruitment and incentive strategies for body acceptance programs on college women
por: Perez, Marisol, et al.
Publicado: (2016)

Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities
por: Sedighi, Mansour, et al.
Publicado: (2019)

Personalised medicine in sleep respiratory disorders: focus on obstructive sleep apnoea diagnosis and treatment
por: Bonsignore, Maria R., et al.
Publicado: (2017)

Challenges and Opportunities of Airborne Metagenomics
por: Behzad, Hayedeh, et al.
Publicado: (2015)

Ongoing and future COVID-19 vaccine clinical trials: challenges and opportunities
por: Dal-Ré, Rafael, et al.
Publicado: (2021)

Marine-Derived Pharmaceuticals – Challenges and Opportunities
por: Lindequist, Ulrike
Publicado: (2016)

Zeolite in tissue engineering: Opportunities and challenges
por: Zarrintaj, Payam, et al.
Publicado: (2020)

Sharing data from MS clinical trials: Opportunities, challenges, and future directions
por: Coetzee, Timothy
Publicado: (2015)

Precision medicine and personalising therapy in pulmonary hypertension: seeing the light from the dawn of a new era
por: Savale, Laurent, et al.
Publicado: (2018)

Cost‐effectiveness of multiparametric magnetic resonance imaging and MRI‐guided biopsy in a population‐based prostate cancer screening setting using a micro‐simulation model
por: Getaneh, Abraham M., et al.
Publicado: (2021)

Integrated OMICS tools for personalised medicine
por: Borro, Marina, et al.
Publicado: (2015)

Breast cancer risk stratification for mammographic screening: A nation‐wide screening cohort of 24,431 women in Singapore
por: Ho, Peh Joo, et al.
Publicado: (2021)

Maternal vaccination—current status, challenges, and opportunities
por: Kurasawa, Kentaro
Publicado: (2022)

Screening for cancers with a good prognosis: The case of testicular germ cell cancer
por: Heijnsdijk, Eveline A. M., et al.
Publicado: (2021)

Assessment of harms, benefits, and cost‐effectiveness of prostate cancer screening: A micro‐simulation study of 230 scenarios
por: Getaneh, Abraham M., et al.
Publicado: (2020)

Personalised care of patients with stroke in China: a challenge and an opportunity
por: Caplan, Louis R, et al.
Publicado: (2016)

Invited Perspective: Air Pollution and Dementia: Challenges and Opportunities
por: Ritz, Beate, et al.
Publicado: (2021)

Risk stratification and medical therapy of pulmonary arterial hypertension
por: Galiè, Nazzareno, et al.
Publicado: (2019)

Risk stratification of adult T‐cell leukemia/lymphoma using immunophenotyping
por: Kagdi, Huseini H., et al.
Publicado: (2016)

Challenges of agriculture-related eye injuries in Nigeria
por: Kyari, Fatima
Publicado: (2015)

Risk stratification for febrile neutropenia in patients with testicular germ cell tumors
por: Terbuch, Angelika, et al.
Publicado: (2018)

Challenges and opportunities for managing aquatic mercury pollution in altered landscapes
por: Hsu-Kim, Heileen, et al.
Publicado: (2018)

Invited Perspective: PFAS and the Childhood Obesity Phenotype—Challenges and Opportunities
por: Stratakis, Nikos, et al.
Publicado: (2023)

Sustainable Systems Engineering: Opportunities and Challenges
por: van der Aalst, Wil M. P., et al.
Publicado: (2023)

Investigator led trials: challenges and opportunities
por: Sandercock, Peter
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_74ncsmndot79arksc4il99jgoa